 |
|
Preparing a Label in a Lab
|
|
In coordination with others, this group is responsible for
defining the details and specifications of the manufacturing
process and final product. Working with clinical research, they
determine the form of the product (tablet or injectable), how it
will be produced, the non-active ingredients (such as lactose or
sucrose sugars), and the best way to make it. They identify
critical control parameters that are used in validating the
process.
Example of a GMP expectation that applies to Product Development
The written process instructions describe the
in-process controls to be conducted in order to assure batch uniformity
and integrity.
Example of GMP requirements specific to this GMP expectation
U.S.
-
To assure batch uniformity and integrity of
drug products, written procedures shall be established and
followed that describe the in-process controls, and tests, or
examinations to be conducted on appropriate samples of
in-process materials of each batch. Such control procedures
shall be established to monitor the output and to validate the
performance of those manufacturing processes that may be
responsible for causing variability in the characteristics of
in-process material and the drug product. [211.110(a)]
Canada
European Union
-
The processing instructions should include
the instructions for any in-process controls with their
limits. [EU # 4.15(d)]
-
There should be written procedures for
testing materials and products at different stages of
manufacture, describing the methods and equipment to be used.
The tests performed should be recorded. [EU # 4.23]
|